DermTech, Inc. announced that Dr. John Dobak expects to step away from his role as president and director under a planned transition. Dr. John Dobak will continue to serve as president and director until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3188 USD | +0.57% | -5.82% | -81.78% |
14/05 | DermTech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/05 | Earnings Flash (DMTK) DERMTECH Posts Q1 Revenue $3.8M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-81.78% | 11.15M | |
-9.74% | 11.48B | |
-9.80% | 7.64B | |
+27.84% | 5.49B | |
-15.47% | 3.86B | |
+8.47% | 2.61B | |
-63.81% | 2.42B | |
-9.24% | 2.27B | |
+21.21% | 2.1B | |
-9.38% | 1.76B |
- Stock Market
- Equities
- DMTK Stock
- News DermTech, Inc.
- DermTech, Inc. Announces John Dobak Expects to Step Away as President and Director